1. Home
  2. AYTU vs SOGP Comparison

AYTU vs SOGP Comparison

Compare AYTU & SOGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • SOGP
  • Stock Information
  • Founded
  • AYTU N/A
  • SOGP 2010
  • Country
  • AYTU United States
  • SOGP Singapore
  • Employees
  • AYTU N/A
  • SOGP N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • SOGP
  • Sector
  • AYTU Health Care
  • SOGP
  • Exchange
  • AYTU Nasdaq
  • SOGP NYSE
  • Market Cap
  • AYTU 10.7M
  • SOGP 12.8M
  • IPO Year
  • AYTU N/A
  • SOGP 2020
  • Fundamental
  • Price
  • AYTU $1.51
  • SOGP $1.69
  • Analyst Decision
  • AYTU
  • SOGP
  • Analyst Count
  • AYTU 0
  • SOGP 0
  • Target Price
  • AYTU N/A
  • SOGP N/A
  • AVG Volume (30 Days)
  • AYTU 45.2K
  • SOGP 11.6K
  • Earning Date
  • AYTU 11-13-2024
  • SOGP 12-03-2024
  • Dividend Yield
  • AYTU N/A
  • SOGP N/A
  • EPS Growth
  • AYTU N/A
  • SOGP N/A
  • EPS
  • AYTU N/A
  • SOGP N/A
  • Revenue
  • AYTU $79,759,000.00
  • SOGP $298,906,204.00
  • Revenue This Year
  • AYTU N/A
  • SOGP $37.39
  • Revenue Next Year
  • AYTU $2.35
  • SOGP $3.88
  • P/E Ratio
  • AYTU N/A
  • SOGP N/A
  • Revenue Growth
  • AYTU N/A
  • SOGP N/A
  • 52 Week Low
  • AYTU $1.41
  • SOGP $1.49
  • 52 Week High
  • AYTU $3.45
  • SOGP $6.70
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 26.32
  • SOGP 44.38
  • Support Level
  • AYTU $1.41
  • SOGP $1.58
  • Resistance Level
  • AYTU $1.63
  • SOGP $1.79
  • Average True Range (ATR)
  • AYTU 0.21
  • SOGP 0.13
  • MACD
  • AYTU -0.01
  • SOGP 0.00
  • Stochastic Oscillator
  • AYTU 11.98
  • SOGP 34.07

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)

Sound Group Inc is a global audio-centric social and entertainment company. It Leverages broad product portfolio and advanced in-house technologies, Sound Group caters to global user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions worldwide.

Share on Social Networks: